SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-046945
Filing Date
2021-12-06
Accepted
2021-12-06 16:13:53
Documents
2
Period of Report
2021-12-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1571
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4816
  Complete submission text file 0000899243-21-046945.txt   7774
Mailing Address 1325 BOYLSTON STREET SUITE 500 BOSTON MA 02215
Business Address 1325 BOYLSTON STREET SUITE 500 BOSTON MA 02215 617-370-8701
Decibel Therapeutics, Inc. (Issuer) CIK: 0001656536 (see all company filings)

IRS No.: 464198709 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BLUEBIRD BIO, INC. 60 BINNEY STREET CAMBRIDGE MA 02142
Business Address
FINGER ALISON CECILY (Reporting) CIK: 0001731164 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40030 | Film No.: 211473323